Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
60 participants
INTERVENTIONAL
2022-12-01
2023-01-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Laser Puncture on Liver Enzymes Post Burn
NCT05728450
Donor Site Healing Response to Low Level Laser Therapy Following Skin Graft Surgery
NCT05907915
Efficacy of Different Densities of Fractional Carbon Dioxide in Treatment of Post Burn Scars
NCT03416660
Potential Benefits of Laser Treatment on Skin Blood Flow and Sweating in Burn Survivors
NCT04947449
COMPARISON STUY OF KINESIOTAPE AND LOW-LEVEL LASER THERAPY ON HYPERTROPHIC SCAR
NCT07209891
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. Age may significantly affect burn wound healing's response to low level laser therapy.
2. TBSA may significantly affect burn wound healing's response to low level laser therapy.
3. Depth of wound may significantly affect burn wound healing's response to low level laser therapy.
4. Wound healing stage may significantly affect burn wound healing's response to low level laser therapy. There will be only one intervention group. The duration of the study will be 6 weeks divided to 18 sessions (three sessions per week). Sixty patients (male and female) will be recruited from the burn units.
Low level laser therapy will be performed for 30 min 3 times per week for 8 weeks on the wound area.
Wound area was irradiated by a red 655 nm light, 150 mW, 2 J/cm2 at the bed of the wound.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
burn wound receiving low level laser therapy
low level laser therapy
Low level laser therapy will be performed for 30 min 3 times per week for 8 weeks on the wound area.
Wound area was irradiated by a red 655 nm light, 150 mW, 2 J/cm2 at the bed of the wound.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
low level laser therapy
Low level laser therapy will be performed for 30 min 3 times per week for 8 weeks on the wound area.
Wound area was irradiated by a red 655 nm light, 150 mW, 2 J/cm2 at the bed of the wound.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age ranges from 20-50 years.
* TBSA more than 15%
* Sufficient understanding to perform the test
Exclusion Criteria
* Burn wound with skin graft
* Infected wounds
* Patients receiving immunosuppressive drugs.
* Patients receiving irradiation or chemotherapy.
* Chronic circulatory diseases
* Severe associated injury with burn.
* Associated co-morbidities, such as neurological diseases, malnutrition, and other inflammatory and/or infectious diseases.
20 Years
50 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cairo University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
ahmed mohamed nagy
lecturer of physical therapy for surgery- Cairo university
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cairo university
Giza, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
P.T.REC/012/003532
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.